Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CXCR6-transduced T cells for targeted tumor therapy

CXCR6-transduced T cells for targeted tumor therapy

US Patent 11723922 · Granted Aug 15, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific antigen binding molecules comprising anti-FAP clone 2122025
Bispecific antigen binding molecules capable of specific binding to CD40 and to 2024
Bispecific antibody molecules with antigen-transfected T-cells and their use in 2023
Bispecific antibody molecules with antigen-transfected T-cells and their use in 2023
Adoptive t-cell therapy2023
Adoptive t-cell therapy2023
Bispecific antigen binding molecules comprising anti-FAP clone 2122022
PD-1-CD28 fusion proteins and their use in medicine2021
PD-1-CD28 fusion proteins and their use in medicine2021
Bispecific antibody molecules with antigen-transfected T-cells and their use in 2020
Bispecific antibody molecules with antigen-transfected T-cells and their use in 2020
Method of stimulating an immune response and inhibiting expression of a gene usi2011